Bios Equity COF, LP

Insider Reports History

Entity
Company
Location
1751 River Run, Suite 400, Fort Worth, TX
Signature
Bios Equity COF, LP By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ Daniel Schwarz, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bios Equity COF, LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 980K Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 300K Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 131K Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 31.9K Aug 12, 2024 Directly held by BP Directors, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 15K Aug 12, 2024 Directly held by Aaron G.L. Fletcher
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Convertible Note 0 Aug 14, 2024 Directly held by Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Actuate Co-Invest III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 Aug 14, 2024 Directly held by Bios Fund II QP, LP

Insider Reports Filed by Bios Equity COF, LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 3 -$200K 4/A Aug 20, 2024 Director, 10%+ Owner